Status and Influencing Factors of HIV/AIDS Patients Co-infected with Hepatitis C Virus in Guizhou

Background The status of patients with HIV/AIDS co-infected with HCV considerably varies in different parts of China. The co-infection of HIV and HCV accelerates the clinical progress of the disease, thereby reducing the patients' quality of life and exacerbating the occurrence of death. Currently, there are relatively few studies on patients with HIV/AIDS co-infected with HCV in Guizhou. Objective To analyze the status of patients with HIV/AIDS co-infected with HCV in Guizhou and its influencing factors and consequently provide basis for its early detection, diagnosis, and treatment. Methods The cases included in this study were a cohort of HIV/AIDS patients who received antiviral therapy (ART) in the public health rescue center of Guangzhou from March 2006 to December 2020. Finally, 3 084 patients who met the study requirements were included. Patients' sex, age, ethnicity, education level, occupation, marital status, route of infection, year of diagnosis, and CD4+ T-lymphocytes before ART and anti HCV levels were collected. Multivariate Logistic regression model were used to identify influencing factors of patients with HIV/AIDS co-infected with HCV. Results Among the 3 084 patients with HIV/AIDS, 202 were co-infected with HCV, and the co-infection rate was 6.55%. There were significant differences in HCV infection rates among patients with HIV/AIDS of different age groups, education levels, occupations, route of infection (P0.05) . The prevalence of HCV infection among HIV/AIDS patients tended to decrease with increasing year of diagnosis and increasing levels of CD4+ T lymphocytes (P